155 related articles for article (PubMed ID: 6376356)
1. In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.
Colizzi V
Infect Immun; 1984 Jul; 45(1):25-8. PubMed ID: 6376356
[TBL] [Abstract][Full Text] [Related]
2. Low doses of recombinant interleukin-2 enhance delayed type hypersensitivity to PPD in mice infected with Mycobacterium bovis-BCG and fed a diet supplemented with vitamin A acetate.
Ferraro F; Mattei M; Colizzi V
Z Erkr Atmungsorgane; 1988; 171(1):45-9. PubMed ID: 3057751
[TBL] [Abstract][Full Text] [Related]
3. The combined administration of thymomodulin and interleukin 2 reverses T-cell unresponsiveness in mice infected with Mycobacterium bovis-BCG.
Colizzi V; Cazzola P; Mazzanti P
Int J Immunopharmacol; 1988; 10(3):271-5. PubMed ID: 3263332
[TBL] [Abstract][Full Text] [Related]
4. Acquired immunity to heavy infection with Mycobacterium bovis bacillus Calmette-Guérin and its relationship to the development of nonspecific unresponsiveness in vitro.
Orme IM; Ratcliffe MJ; Collins FM
Cell Immunol; 1984 Oct; 88(2):285-96. PubMed ID: 6386183
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of antigen-specific proliferation and IL-2/IL-4 production of spleen cells from mice infected with Mycobacterium bovis BCG].
Teruya K; Kawakami K; Tohyama M; Saito A
Kekkaku; 1995 Apr; 70(4):293-9. PubMed ID: 7760538
[TBL] [Abstract][Full Text] [Related]
6. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
Kramnik I; Radzioch D; Skamene E
Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenicity of interleukin 12 and DNA vaccine prime-BCG boost against Mycobacterium tuberculosis].
Gao L; Bao L; Hao M; Zhang L; Qin ZF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):535-9. PubMed ID: 18798487
[TBL] [Abstract][Full Text] [Related]
8. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice.
Huygen K; Abramowicz D; Vandenbussche P; Jacobs F; De Bruyn J; Kentos A; Drowart A; Van Vooren JP; Goldman M
Infect Immun; 1992 Jul; 60(7):2880-6. PubMed ID: 1612754
[TBL] [Abstract][Full Text] [Related]
9. Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis.
McMurray DN; Mintzer CL; Bartow RA; Parr RL
Infect Immun; 1989 Sep; 57(9):2606-11. PubMed ID: 2788135
[TBL] [Abstract][Full Text] [Related]
10. T cell responses to Mycobacterium bovis in red deer, a large animal model for tuberculosis.
Cross ML; Chinn ND; Griffin JF; Buchan GS
Immunol Cell Biol; 1996 Feb; 74(1):32-7. PubMed ID: 8934651
[TBL] [Abstract][Full Text] [Related]
11. Immunological consequences of innate resistance and susceptibility to BCG.
Buschman E; Skamene E
Immunol Lett; 1988 Nov; 19(3):199-209. PubMed ID: 3069707
[TBL] [Abstract][Full Text] [Related]
12. Study of DTH and resistance in Mycobacterium lepraemurium infection using a T-cell line isolated from mice infected with Mycobacterium bovis (BCG).
Hussein S; Curtis J; Griffiths D; Turk JL
Cell Immunol; 1987 Apr; 105(2):423-31. PubMed ID: 3032464
[TBL] [Abstract][Full Text] [Related]
13. [BCG-induced T cell anergy and its activation by IL-4].
Nishioka Y; Nakanishi K; Sugita M
Arerugi; 1998 May; 47(5):533-42. PubMed ID: 9656576
[TBL] [Abstract][Full Text] [Related]
14. Frequencies of IFN gamma- and IL-4-producing cells during Mycobacterium bovis BCG infection in two genetically susceptible mouse strains: role of alpha/beta T cells and NK1.1 cells.
Teixeira HC; Munk ME; Kaufmann SH
Immunol Lett; 1995 May; 46(1-2):15-9. PubMed ID: 7590911
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium bovis BCG-infected mice are more susceptible to staphylococcal enterotoxin B-mediated toxic shock than uninfected mice despite reduced in vitro splenocyte responses to superantigens.
Pedras-Vasconcelos JA; Chapdelaine Y; Dudani R; van Faassen H; Smith DK; Sad S
Infect Immun; 2002 Aug; 70(8):4148-57. PubMed ID: 12117923
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 production in Mycobacterium bovis BCG-infected mice.
Huygen K; Vandenbussche P; Heremans H
Cell Immunol; 1991 Oct; 137(1):224-31. PubMed ID: 1679380
[TBL] [Abstract][Full Text] [Related]
17. Coadministration of interleukins 7 and 15 with bacille Calmette-Guérin mounts enduring T cell memory response against Mycobacterium tuberculosis.
Singh V; Gowthaman U; Jain S; Parihar P; Banskar S; Gupta P; Gupta UD; Agrewala JN
J Infect Dis; 2010 Aug; 202(3):480-9. PubMed ID: 20569158
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying the depressed production of interleukin-2 in spleen and lymph node cell cultures of mice infected with Mycobacterium bovis BCG.
Turcotte R; Legault D
Infect Immun; 1986 Mar; 51(3):826-31. PubMed ID: 3081445
[TBL] [Abstract][Full Text] [Related]
19. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. II. Production of interleukins 2, 4, and 6 and of interferon-gamma by draining lymph node cells.
Roch F; Bach MA
Clin Immunol Immunopathol; 1991 Sep; 60(3):443-54. PubMed ID: 1907533
[TBL] [Abstract][Full Text] [Related]
20. The effect of Bcg gene on antigen presentation of spleen adherent cells and peritoneal macrophages from Mycobacterium bovis BCG-infected Bcg(s) and Bcg(r) mice.
Xu DL; Goto Y; Endo F; Amoako KK; Shinjo T
Vet Microbiol; 1997 Dec; 59(1):67-78. PubMed ID: 9460198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
